InsiderClue
← All stocks

GENELUX Corp

GNLX Net selling
CIK 0001231457 #4219 in the set updated 17 Sep 2026
Bought (120 mo)
$1.25K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.76M
$113.26K on a plan · $1.03M straight out of an exercise
Sold at will
$15.62M
125 of 139 sales
Net
−$16.76M
−$15.61M against sales at will

By person

17 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Szalay Aladar
10% owner
—
$11.81M (59)
−$11.81M
599,821
1.33%
$1.65M
−23.7%
Yu Yong
Chief Scientific Officer
— (1)
$3.27M (26)
−$3.27M
258,688
0.5717%
$712.19K
+65.5%
Thomas John
Director
— (1)
$454.50K (10)
−$454.50K
501,193
1.11%
$1.38M
—
Zindrick Thomas
President and CEO
— (1)
$447.12K (9)
−$447.12K
1,426,427
3.15%
$3.93M
+21,257%
Ryder Sean
General Counsel
— (1)
$332.50K (4) scheduled
−$332.50K
47,621
0.1053%
$131.11K
+2,161%
Cappello Joseph
Chief Technical Officer
—
$154.44K (10)
−$154.44K
318,480
0.7039%
$876.81K
—
Tyree James L
Director
— (1)
$131.98K (4)
−$131.98K
96,483
0.2132%
$265.63K
+5,477%
Smither John W
Director
— (1)
$53.60K (2)
−$53.60K
91,403
0.2020%
$251.64K
+10,056%
Smalling Ralph
Head of Regulatory
— (1)
$43.28K (11)
−$43.28K
67,611
0.1494%
$186.14K
+1,067%
Samuelson Doug
Vice President, Finance
—
$30.78K (1)
−$30.78K
2,303
0.0051%
$6.34K
—
Jewett Caroline
Head of Quality
—
$22.74K (2)
−$22.74K
16,174
0.0357%
$44.53K
—
Zak Lourie S.
Chief Financial Officer
— (1)
$4.92K (1)
−$4.92K
82,452
0.1822%
$227.00K
+1,152%
Zhang Qian
Associate VP, Research
$1.25K (1)
—
+$1.25K
139,533
0.3084%
$384.15K
+4.7%
Mirabelli Mary
Director
— (1)
—
$0.00
102,693
0.2270%
$282.72K
—
Pulisic Matthew
Chief Financial Officer
—
—
—
278,906
0.6164%
$767.86K
—
Groen Eric
General Counsel
—
—
—
233,957
0.5171%
$644.11K
—
Woodward Gabe
Director
—
—
—
6,984
0.0154%
$19.23K
—

Individual transactions

149
Insider
Date
Role
Action
Shares
Price
Amount
Yu Yong
31 Aug 2026
Chief Scientific Officer
Sell
9,683
$2.75
$26.66K
Zindrick Thomas
31 Aug 2026
President and CEO
Sell
34,463
$2.67
$91.90K
Cappello Joseph
31 Aug 2026
Chief Technical Officer
Sell
10,257
$2.74
$28.11K
Zindrick Thomas
4 Aug 2026
President and CEO
Sell
3,023
$2.95
$8.91K
Cappello Joseph
4 Aug 2026
Chief Technical Officer
Sell
653
$2.95
$1.92K
Yu Yong
4 Aug 2026
Chief Scientific Officer
Sell
653
$2.94
$1.92K
Smither John W
1 Jul 2026
Director
Sell
12,000
$2.91
$34.90K
Smalling Ralph
3 Jun 2026
Head of Regulatory
Sell
192
$2.93
$562.56
Thomas John
1 Jun 2026
Director
Sold on a plan
10,000
$2.98
$29.80K
Smalling Ralph
11 May 2026
Head of Regulatory
Sell
270
$2.98
$804.49
Zindrick Thomas
11 May 2026
President and CEO
Sell
2,798
$2.94
$8.23K
Cappello Joseph
11 May 2026
Chief Technical Officer
Sell
605
$2.97
$1.80K
Yu Yong
11 May 2026
Chief Scientific Officer
Sell
605
$2.97
$1.80K
Smalling Ralph
25 Mar 2026
Head of Regulatory
Sell
240
$2.51
$602.40
Zindrick Thomas
24 Mar 2026
President and CEO
Sell
3,582
$2.42
$8.67K
Yu Yong
24 Mar 2026
SVP, Clinical Development
Sell
906
$2.42
$2.19K
Cappello Joseph
24 Mar 2026
Chief Technical Officer
Sell
906
$2.42
$2.19K
Smalling Ralph
24 Mar 2026
Head of Regulatory
Sell
345
$2.42
$834.90
Thomas John
2 Mar 2026
Director
Sold on a plan
10,000
$2.90
$28.96K
Smalling Ralph
5 Dec 2025
Head of Regulatory
Sell
165
$4.69
$773.85
Thomas John
1 Dec 2025
Director
Sold on a plan
10,000
$5.00
$50.01K
Smalling Ralph
17 Nov 2025
Head of Regulatory
Sell
343
$5.37
$1.84K
Cappello Joseph
17 Nov 2025
Chief Technical Officer
Sell
973
$5.37
$5.22K
Zindrick Thomas
17 Nov 2025
President and CEO
Sell
4,509
$5.37
$24.21K
Yu Yong
17 Nov 2025
SVP, Clinical Development
Sell
973
$5.37
$5.22K
Smalling Ralph
3 Sep 2025
Head of Regulatory
Sell
580
$3.36
$1.95K
Smalling Ralph
21 Aug 2025
Head of Regulatory
Sell
1,244
$3.36
$4.18K
Cappello Joseph
21 Aug 2025
Chief Technical Officer
Sell
1,463
$3.36
$4.91K
Cappello Joseph
21 Aug 2025
Chief Technical Officer
Sell
1,270
$3.33
$4.22K
Zindrick Thomas
21 Aug 2025
President and CEO
Sell
12,673
$3.33
$42.16K
Yu Yong
21 Aug 2025
SVP, Clinical Development
Sell
3,219
$3.36
$10.81K
Smalling Ralph
12 May 2025
Head of Regulatory
Sell
1,259
$2.92
$3.68K
Cappello Joseph
12 May 2025
VP, Pharmaceutical Development
Sell
4,737
$2.92
$13.83K
Yu Yong
12 May 2025
VP, Clinical Trial Operations
Sell
5,579
$2.92
$16.29K
Zindrick Thomas
12 May 2025
President and CEO
Sell
10,764
$2.92
$31.43K
Ryder Sean
12 May 2025
General Counsel
Sell
4,475
$2.92
$13.07K
Tyree James L
30 Dec 2024
Director
Sell
3,460
$2.46
$8.51K
Cappello Joseph
16 Dec 2024
VP, Pharmaceutical Development
Sell
6,300
$2.34
$14.74K
Smalling Ralph
16 Dec 2024
Head of Regulatory
Sell
2,510
$2.34
$5.87K
Zak Lourie S.
16 Dec 2024
Chief Financial Officer
Sell
2,103
$2.34
$4.92K
Zindrick Thomas
16 Dec 2024
President and CEO
Sell
14,315
$2.34
$33.50K
Szalay Aladar
13 Sep 2024
10% owner
Sell indirect
33,080
$2.57
$84.95K
Szalay Aladar
12 Sep 2024
10% owner
Sell indirect
31,777
$2.73
$86.73K
Szalay Aladar
11 Sep 2024
10% owner
Sell indirect
31,376
$2.62
$82.23K
Tyree James L
11 Sep 2024
Director
Sold on a plan
1,730
$2.60
$4.50K
Szalay Aladar
10 Sep 2024
10% owner
Sell indirect
20,384
$2.51
$51.18K
Szalay Aladar
9 Sep 2024
10% owner
Sell indirect
23,383
$2.70
$63.20K
Szalay Aladar
3 Sep 2024
10% owner
Sell indirect
42,818
$2.09
$89.61K
Szalay Aladar
30 Aug 2024
10% owner
Sell indirect
142,589
$2.17
$309.85K
Szalay Aladar
29 Aug 2024
10% owner
Sell indirect
107,045
$1.98
$211.96K
Szalay Aladar
28 Aug 2024
10% owner
Sell indirect
15,918
$2.05
$32.60K
Szalay Aladar
27 Aug 2024
10% owner
Sell indirect
51,630
$2.11
$108.86K
Szalay Aladar
23 Aug 2024
10% owner
Sell indirect
40,000
$2.29
$91.42K
Jewett Caroline
24 Jun 2024
Head of Quality
Sell
4,961
$2.12
$10.52K
Ryder Sean
24 Jun 2024
General Counsel
Sell
5,496
$2.12
$11.65K
Yu Yong
24 Jun 2024
VP, Clinical Trial Operations
Sell
6,849
$2.12
$14.52K
Zak Lourie S.
29 May 2024
Chief Financial Officer
Buy
31,250
—
no price
Ryder Sean
29 May 2024
General Counsel
Buy
10,000
—
no price
Smalling Ralph
29 May 2024
Head of Regulatory
Buy
1,250
—
no price
Zindrick Thomas
29 May 2024
President and CEO
Buy indirect
200,000
—
no price
Yu Yong
29 May 2024
VP, Clinical Trial Operations
Buy
2,500
—
no price
Mirabelli Mary
29 May 2024
Director
Buy
8,000
—
no price
Thomas John
29 May 2024
Director
Buy
2,500
—
no price
Smither John W
29 May 2024
Director
Buy
6,250
—
no price
Tyree James L
29 May 2024
Director
Buy
6,250
—
no price
Szalay Aladar
15 May 2024
10% owner
Sell indirect
17,094
$3.66
$62.62K
Szalay Aladar
14 May 2024
10% owner
Sell indirect
15,426
$3.58
$55.27K
Szalay Aladar
13 May 2024
10% owner
Sell indirect
3,446
$3.62
$12.48K
Szalay Aladar
8 May 2024
10% owner
Sell indirect
13,919
$3.82
$53.19K
Szalay Aladar
7 May 2024
10% owner
Sell indirect
6,025
$3.67
$22.11K
Szalay Aladar
1 May 2024
10% owner
Sell indirect
33,061
$3.30
$109.16K
Szalay Aladar
30 Apr 2024
10% owner
Sell indirect
20,535
$3.12
$63.98K
Szalay Aladar
29 Apr 2024
10% owner
Sell indirect
6,403
$3.25
$20.79K
Szalay Aladar
24 Apr 2024
10% owner
Sell indirect
8,064
$3.50
$28.25K
Szalay Aladar
23 Apr 2024
10% owner
Sell indirect
22,000
$3.49
$76.80K
Szalay Aladar
22 Apr 2024
10% owner
Sell indirect
14,331
$3.53
$50.60K
Szalay Aladar
17 Apr 2024
10% owner
Sell indirect
22,737
$3.71
$84.42K
Szalay Aladar
16 Apr 2024
10% owner
Sell indirect
48,683
$3.53
$171.80K
Yu Yong
15 Dec 2023
VP, Clinical Trial Operations
Sell
5,803
$14.18
$82.27K
Yu Yong
15 Dec 2023
VP, Clinical Trial Operations
Sell
26,732
$12.94
$345.91K
Thomas John
13 Dec 2023
Director
Sell
1,927
$13.93
$26.84K
Thomas John
13 Dec 2023
Director
Sell
7,073
$13.23
$93.55K
Tyree James L
13 Dec 2023
Director
Sell
3,347
$13.73
$45.96K
Tyree James L
13 Dec 2023
Director
Sell
5,653
$12.91
$73.01K
Yu Yong
7 Dec 2023
VP, Clinical Trial Operations
Sell
36,800
$11.85
$436.00K
Yu Yong
21 Nov 2023
VP, Clinical Trial Operations
Sell
18,665
$10.26
$191.56K
Yu Yong
20 Nov 2023
VP, Clinical Trial Operations
Sell
14,594
$11.26
$164.26K
Yu Yong
17 Nov 2023
VP, Clinical Trial Operations
Sell
3,541
$13.04
$46.17K
Szalay Aladar
25 Oct 2023
10% owner
Sell indirect
5,704
$19.40
$110.64K
Yu Yong
24 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
5,200
$19.11
$99.35K
Szalay Aladar
23 Oct 2023
10% owner
Sell indirect
49,987
$19.97
$998.37K
Thomas John
16 Oct 2023
Director
Sell
881
$21.30
$18.77K
Thomas John
16 Oct 2023
Director
Sell
2,452
$20.50
$50.27K
Yu Yong
10 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
400
$22.91
$9.16K
Yu Yong
10 Oct 2023
VP, Clinical Trial Operations
Sold after exercise
4,800
$21.94
$105.30K
Szalay Aladar
5 Oct 2023
10% owner
Sell indirect
985
$25.47
$25.09K
Szalay Aladar
5 Oct 2023
10% owner
Sell indirect
13,266
$24.89
$330.14K
Szalay Aladar
3 Oct 2023
10% owner
Sell indirect
75,690
$25.49
$1.93M
Szalay Aladar
28 Sep 2023
10% owner
Sell indirect
2,289
$24.12
$55.21K
Szalay Aladar
27 Sep 2023
10% owner
Sell indirect
11,257
$24.47
$275.46K
Yu Yong
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
2,203
$24.46
$53.89K
Yu Yong
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
1,114
$23.51
$26.20K
Yu Yong
26 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
1,883
$22.54
$42.44K
Szalay Aladar
26 Sep 2023
10% owner
Sell indirect
9,600
$24.51
$235.30K
Szalay Aladar
26 Sep 2023
10% owner
Sell indirect
12,740
$24.03
$306.14K
Szalay Aladar
26 Sep 2023
10% owner
Sell indirect
7,465
$22.47
$167.74K
Szalay Aladar
25 Sep 2023
10% owner
Sell indirect
1,100
$27.81
$30.59K
Szalay Aladar
25 Sep 2023
10% owner
Sell indirect
1,900
$26.60
$50.54K
Szalay Aladar
25 Sep 2023
10% owner
Sell indirect
5,511
$25.75
$141.91K
Szalay Aladar
25 Sep 2023
10% owner
Sell indirect
3,947
$24.82
$97.96K
Szalay Aladar
22 Sep 2023
10% owner
Sell indirect
4,621
$27.76
$128.27K
Szalay Aladar
22 Sep 2023
10% owner
Sell indirect
4,421
$26.88
$118.85K
Szalay Aladar
21 Sep 2023
10% owner
Sell indirect
4,678
$28.82
$134.82K
Szalay Aladar
21 Sep 2023
10% owner
Sell indirect
2,871
$27.89
$80.06K
Ryder Sean
20 Sep 2023
General Counsel
Sold after exercise
10,000
$30.00
$300.00K
Yu Yong
20 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
6,000
$27.96
$167.79K
Szalay Aladar
19 Sep 2023
10% owner
Sell
8,247
$27.16
$223.98K
Szalay Aladar
19 Sep 2023
10% owner
Sell
23,920
$26.21
$626.96K
Thomas John
18 Sep 2023
Director
Sell
3,334
$24.99
$83.32K
Szalay Aladar
18 Sep 2023
10% owner
Sell indirect
2,927
$24.17
$70.75K
Szalay Aladar
18 Sep 2023
10% owner
Sell indirect
27,365
$23.20
$634.90K
Thomas John
15 Sep 2023
Director
Sell
1,088
$22.38
$24.35K
Thomas John
15 Sep 2023
Director
Sell
2,245
$21.67
$48.64K
Yu Yong
15 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
4,675
$22.29
$104.21K
Yu Yong
15 Sep 2023
VP, Clinical Trial Operations
Sold after exercise
5,725
$21.56
$123.42K
Szalay Aladar
14 Sep 2023
10% owner
Sell indirect
13,871
$22.31
$309.52K
Szalay Aladar
14 Sep 2023
10% owner
Sell indirect
11,405
$21.77
$248.28K
Smither John W
13 Sep 2023
Director
Sell
900
$20.78
$18.70K
Szalay Aladar
13 Sep 2023
10% owner
Sell indirect
3,315
$22.31
$73.96K
Szalay Aladar
13 Sep 2023
10% owner
Sell indirect
15,717
$21.26
$334.13K
Yu Yong
13 Sep 2023
VP, Clinical Trial Operations
Sell
29,800
$21.14
$629.93K
Szalay Aladar
12 Sep 2023
10% owner
Sell indirect
13,727
$22.51
$308.94K
Szalay Aladar
12 Sep 2023
10% owner
Sell indirect
6,538
$21.75
$142.23K
Szalay Aladar
11 Sep 2023
10% owner
Sell indirect
23,020
$22.55
$519.16K
Szalay Aladar
11 Sep 2023
10% owner
Sell indirect
9,331
$21.39
$199.55K
Szalay Aladar
8 Sep 2023
10% owner
Sell indirect
2,636
$24.19
$63.75K
Szalay Aladar
8 Sep 2023
10% owner
Sell indirect
8,523
$23.49
$200.17K
Szalay Aladar
8 Sep 2023
10% owner
Sell indirect
13,672
$22.78
$311.41K
Szalay Aladar
7 Sep 2023
10% owner
Sell indirect
2,508
$25.34
$63.55K
Szalay Aladar
7 Sep 2023
10% owner
Sell indirect
9,938
$24.12
$239.72K
Yu Yong
30 Aug 2023
VP, Clinical Trial Operations
Sell
19,800
$24.70
$489.06K
Zindrick Thomas
18 Aug 2023
President and CEO
Sell
8,349
$23.73
$198.12K
Yu Yong
18 Aug 2023
VP, Clinical Trial Operations
Sell
3,265
$23.73
$77.48K
Cappello Joseph
18 Aug 2023
VP, Pharmaceutical Development
Sell
3,265
$23.73
$77.48K
Ryder Sean
18 Aug 2023
General Counsel
Sell
328
$23.73
$7.78K
Samuelson Doug
18 Aug 2023
Chief Financial Officer
Sell
1,297
$23.73
$30.78K
Smalling Ralph
18 Aug 2023
Head of Regulatory
Sell
935
$23.73
$22.19K
Jewett Caroline
18 Aug 2023
Head of Quality
Sell
515
$23.73
$12.22K
Zhang Qian
26 Jan 2023
Associate VP, Research
Buy indirect
200
$6.25
$1.25K

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 10
Sales at will 125
Transactions with no price 9
Shares from compensation/vesting 4,605,497
History held since 30 Jan 2023